An expanded treatment protocol of panobinostat in combination therapy for relapsed and relapsed and refractory (RR) cancer of plasma cells

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003239-21

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

- To provide multiple myeloma patients early access to treatment with panobinostat and to further evaluate safety of panobinostat when used in combination with BTZ/Dex in patients with multiple myeloma who have received at least two prior regimens including bortezomib and an immunomodulatory agent.


Critère d'inclusion

  • Multiple myeloma